Page last updated: 2024-08-16

sb 206553 and sb 200646a

sb 206553 has been researched along with sb 200646a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baxter, GS; Blackburn, TP; Booth, DH; Forbes, IT; Glen, A; Ham, P; Kennett, GA; Martin, RT; Thompson, M; Wood, MD	1

Other Studies

1 other study(ies) available for sb 206553 and sb 200646a

Article	Year
5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activity. Journal of medicinal chemistry, 1995, Jul-07, Volume: 38, Issue:14 Topics: Administration, Oral; Animals; Indoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Pyridines; Rats; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin Antagonists	1995

Article

Year

5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activity.

Journal of medicinal chemistry, 1995, Jul-07, Volume: 38, Issue:14

Topics: Administration, Oral; Animals; Indoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Pyridines; Rats; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin Antagonists

1995